The basis for this assumption comes from studies showing that markers of inflammation such as TNF-α, IL-1β, IL-6, and other cytokines are increased in the brain, cerebrospinal fluid, and plasma of AD patients [10,169,170,171]. The gene discussed is TNF; the disease is Alzheimer disease.